NCT01431989View on ClinicalTrials.gov

Amoxicillin Bioequivalence Study Brazil - Fast

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

May 27, 2011

Primary Completion Date

June 11, 2011

Study Completion Date

June 11, 2011

Conditions

Infections, Bacterial

Interventions

DRUG

Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL

Test formulation

DRUG

Amoxil® 500mg/5mL powder for oral suspension

Reference formulation

Trial Locations (1)

Unknown

GSK Investigational Site, Goiânia

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01431989 - Amoxicillin Bioequivalence Study Brazil - Fast | Biotech Hunter | Biotech Hunter